Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 235 | -195 | 774 | 309 | 603 |
| Gross Profit | 235 | -195 | 774 | 309 | 603 |
| Operating Expenses | 18,534 | 257,244 | 19,749 | 195,557 | 20,580 |
| Operating Income | -18,299 | -257,439 | -18,975 | -195,248 | -19,977 |
| Interest Expense | 42 | 0 | 0 | 0 | 0 |
| Other Income | -286 | -1,394 | -620 | 384 | 4,103 |
| Pre-tax Income | -18,627 | -258,833 | -19,595 | -194,864 | -15,874 |
| Income Tax | N/A | -40,138 | N/A | -64,864 | N/A |
| Net Income Continuous | -18,627 | -218,695 | -19,595 | -130,000 | -15,874 |
| Net Income | $-18,627 | $-218,695 | $-19,595 | $-130,000 | $-15,874 |
| EPS Basic Total Ops | -0.34 | -4.09 | -0.37 | -2.47 | -0.31 |
| EPS Basic Continuous Ops | -0.34 | -4.10 | -0.37 | -2.47 | -0.31 |
| EPS Diluted Total Ops | -0.34 | -4.09 | -0.37 | -2.47 | -0.31 |
| EPS Diluted Continuous Ops | -0.34 | -4.10 | -0.37 | -2.47 | -0.31 |
| EBITDA(a) | $-17,965 | $-22,084 | $-18,684 | $-38,672 | $-19,760 |